Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1987-2-25
pubmed:abstractText
Paired liver biopsy specimens and serum samples from 76 patients with chronic hepatitis B virus (HBV) infection were taken for staining of hepatitis B core antigen (HBcAg) by immunoperoxidase and testing of HBV-DNA by a spot hybridization technique, respectively. Thirty-two tissue specimens showed positive staining for HBcAg in their hepatocytes. The two patients with diffuse HBcAg expression in liver tissue also had high serum concentrations of HBV-DNA (greater than 10 pg/10 microL). Among 30 patients with focal HBcAg distribution, 28 patients (93.3%) had measurable levels of serum HBV-DNA and 17 patients (60.7%) had high levels of serum HBV-DNA. Of 44 patients without hepatic HBcAg expression, only 12 patients (27.3%) had detectable serum HBV-DNA, and most patients (93.1% [11/12]) had low concentrations (less than 10 pg/10 microL). Nineteen patients had superimposed hepatitis D virus infection, and, of these, three patients (15.8%) had detectable serum HBV-DNA in low concentrations, while one of the three patients had stainable HBcAg in his hepatocytes with focal distribution. Two of the three patients with hepatitis A virus superinfection who had focal HBcAg expression in their liver tissue had serum HBV-DNA levels that were high during the acute phase of hepatitis A virus infection, and in one patient his serum HBV-DNA levels further increased from 10 pg/10 microL to 40 pg/10 microL during the recovery phase. Thus, measurement of serum HBV-DNA levels in patients with chronic HBV infection correlated well with their hepatic HBcAg expression, and both represent the precise status of HBV replication.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0003-9985
pubmed:author
pubmed:issnType
Print
pubmed:volume
111
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
181-4
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:3545139-Adolescent, pubmed-meshheading:3545139-Adult, pubmed-meshheading:3545139-Aged, pubmed-meshheading:3545139-Biopsy, Needle, pubmed-meshheading:3545139-Carrier State, pubmed-meshheading:3545139-Chronic Disease, pubmed-meshheading:3545139-DNA, Viral, pubmed-meshheading:3545139-Female, pubmed-meshheading:3545139-Hepatitis, Chronic, pubmed-meshheading:3545139-Hepatitis A, pubmed-meshheading:3545139-Hepatitis B, pubmed-meshheading:3545139-Hepatitis B Core Antigens, pubmed-meshheading:3545139-Hepatitis B virus, pubmed-meshheading:3545139-Hepatitis D, pubmed-meshheading:3545139-Humans, pubmed-meshheading:3545139-Immunoenzyme Techniques, pubmed-meshheading:3545139-Liver, pubmed-meshheading:3545139-Male, pubmed-meshheading:3545139-Middle Aged, pubmed-meshheading:3545139-Taiwan
pubmed:year
1987
pubmed:articleTitle
Correlation between hepatic hepatitis B core antigen and serum hepatitis B virus-DNA levels in patients with chronic hepatitis B virus infections in Taiwan.
pubmed:publicationType
Journal Article